{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:24:36Z","timestamp":1740173076393,"version":"3.37.3"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jcte.2024.100352","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T04:25:05Z","timestamp":1716006305000},"page":"100352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience"],"prefix":"10.1016","volume":"36","author":[{"given":"Laya","family":"Ekhlaspour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Buckingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7569-2051","authenticated-orcid":false,"given":"Colleen","family":"Bauza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Neyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Norlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Schamberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy W.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Kollman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Cobry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda A.","family":"DiMeglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Paprocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Van Name","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2024.100352_b0005","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100352_b0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/db07-0715","article-title":"Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis","volume":"57","author":"Chen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2024.100352_b0015","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jama.2023.2064","article-title":"Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial","volume":"329","author":"Forlenza","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jcte.2024.100352_b0020","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jcte.2024.100352_b0025","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.2023.2063","article-title":"Effect of tight glycemic control on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial","volume":"329","author":"McVean","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jcte.2024.100352_b0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9149(81)90077-1","article-title":"Effects of verapamil on supraventricular tachycardia in children","volume":"48","author":"Porter","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcte.2024.100352_b0035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1542\/peds.71.5.748","article-title":"Verapamil: an effective calcium blocking agent for pediatric patients","volume":"71","author":"Porter","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcte.2024.100352_b0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670000480","article-title":"Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension","volume":"15","author":"Flynn","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2024.100352_b0045","first-page":"149S","article-title":"Pharmacokinetics of conventional and slow-release verapamil","volume":"21","author":"Follath","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcte.2024.100352_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/oxfordjournals.eurheartj.a061546","article-title":"Ambulatory electrocardiographic findings in young athletes between 14 and 16 years of age","volume":"5","author":"Viitasalo","year":"1984","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcte.2024.100352_b0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/hrt.51.2.179","article-title":"Ambulatory electrocardiographic monitoring in 100 healthy teenage boys","volume":"51","author":"Dickinson","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.jcte.2024.100352_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-198938010-00003","article-title":"An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension","volume":"38","author":"McTavish","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.jcte.2024.100352_b0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1742-7843.2010.00666.x","article-title":"Predictors of mortality in verapamil overdose: usefulness of serum verapamil concentrations","volume":"108","author":"Megarbane","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jcte.2024.100352_b0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1177\/106002809202601106","article-title":"Verapamil overdose: case report and review of the literature","volume":"26","author":"Watling","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcte.2024.100352_b0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.paf.0000257399.58935.28","article-title":"Verapamil toxicity: an unusual case report and review of the literature","volume":"28","author":"Batalis","year":"2007","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.jcte.2024.100352_b0080","unstructured":"Calan - verapamil hydrochloride tablet package insert. In: Pfizer, editor. NY, NY 10017: G.D. Searle LLC; 2009."},{"key":"10.1016\/j.jcte.2024.100352_b0085","doi-asserted-by":"crossref","first-page":"e4063","DOI":"10.1210\/clinem\/dgac436","article-title":"A randomized controlled trial of R-form verapamil added to ongoing metformin therapy in patients with type 2 diabetes","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2024.100352_b0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SMJ.0b013e3181928f81","article-title":"Grapefruit juice and verapamil: a toxic cocktail","volume":"102","author":"Pillai","year":"2009","journal-title":"South Med J"},{"key":"10.1016\/j.jcte.2024.100352_b0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/clpt.1992.96","article-title":"Verapamil inhibits ethanol elimination and prolongs the perception of intoxication","volume":"52","author":"Bauer","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcte.2024.100352_b0100","unstructured":"Calan SR oral caplets. Pfizer. NY, NY 10017: G.D. Searle LLC; 2017."},{"key":"10.1016\/j.jcte.2024.100352_b0105","first-page":"485","article-title":"Verapamil-induced hepatotoxicity","volume":"160","author":"Kumar","year":"1994","journal-title":"West J Med"},{"key":"10.1016\/j.jcte.2024.100352_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jama.1983.03330270059036","article-title":"Hepatic injury possibly induced by verapamil","volume":"249","author":"Nash","year":"1983","journal-title":"JAMA"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:19:13Z","timestamp":1718900353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623724000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":22,"alternative-id":["S2214623724000231"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100352","relation":{},"ISSN":["2214-6237"],"issn-type":[{"type":"print","value":"2214-6237"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100352"}}